Tumor-infiltrating CD3+CD8+ and CD3+CD4+ T cells were greatly increased in mice treated with PMA-TCLV and aPD-L1 compared with in the groups treated with TCLV or control group (figure 3K). The gene discussed is CD8A; the disease is neoplasm.